Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to csearle,brightncheerful,Dormouse,Silverstar64,dave559, for Donating to support the site

MrC's Smallcap Sweeps for Feb 2021

Discuss Shares, buying selling, tips and deals
MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

MrC's Smallcap Sweeps for Feb 2021

#382635

Postby MrContrarian » February 1st, 2021, 7:57 am

Smallcap Sweep. 01-Feb-21


Bidstack (BIDS) guides FY(Dec) rev c.£1.7m, above mkt exp. Pretax c. -£7.18m (-£5.6m). Warns "the pandemic may well result in a further lengthening of sales cycles. To address this, Bidstack's strategy will be to concentrate on the appropriate implementation of its technology even if this is at the expense of some short term opportunities." [SP=10.75 Cap=42m]
Tracsis (TRCS) new CFO today. Outgoing is thanked. [SP=650 Cap=190m]
Avacta (AVCT) AffyXell Therapeutics JV gets $7.3m VC funding. [SP=123 Cap=311m]
Iconic Labs (ICON) gets termination notice for mgmt of JOE Media and TheLondonEconomic businesses citing today's resignation of the senior management team of John Quinlan, Sam Asante and Liam Harrington. This is the most significant proportion of co's rev. JOE media termination immediate effect. [SP=0.01 Cap=2m]
Remote Monitored Systems (RMS) commissioning of anti-viral mask manufacturing machine delayed because the engineers have caught guess what? Covid. [SP=2.45 Cap=49m]
Zytronic (ZYT) Tender Offer at 145p, a 14% premium, to return up to £10m. [SP=135 Cap=22m]
Hardide (HDD) £775k min placing at 30.9p, a 5% discount. Needed in case oil mkt demand slow to recover. [SP=31 Cap=16m]
Sportech (SPO) sells Bump Worldwide for c. £5.7m including c.£1.1m earn out. [SP=27.6 Cap=52m]
DX (DX.) guides FY(July) adj pretax materially above market expectations after strong H1. Cites strong progress at DX Freight, [SP=35.5 Cap=204m]
Netcall (NET) guides H1 rev up 9% and adj EBITDA up 38%, comfortably in line with management expectations. [SP=57.5 Cap=85m]
IDE (IDE) guides FY(Dec) rev £23.6m down 16% and adj EBITDA £0.5m (£1.1m). In line implied. Cost savings to come though this FY. [SP=2.25 Cap=9m]
Venture Life (VLG) guides FY(Dec) rev up 49% and adj EBITDA over double. In line? "The significantly increased revenues and higher prevalence of revenues from the VLG Brands in the year have contributed to improving gross margin, as expected. Revenues from the newly acquired PharmaSource business were ahead of 2019, and a number of planned synergies have already been achieved." [SP=87 Cap=109m]
Parity (PTY) wins 3-6 year contact worth up to £5m from Scotland. [SP=9 Cap=9m]
Staffline (STAF) guides FY(Dec) U/L op profit marginally ahead of expectations. "Board continues to evaluate its options in relation to strengthening the Group's finances." [SP=55.5 Cap=38m]
Totally (TLY) 1 year contract extensions worth c. £16.8m [SP=32 Cap=58m]
Air China (AIRC) RNS called 'Profit Warning'. How refreshing. Guides FY(Dec) loss RMB13.5bn to RMB15.5bn. [SP=0 Cap=112667m]

In line: RWI, SEE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#382948

Postby MrContrarian » February 2nd, 2021, 7:35 am

Smallcap Sweep. 02-Feb-21
SPSY busy

Diurnal (DNL) extention to Phase II study showed Chronocort suitable and safe for the rare condition congenital adrenal hyperplasia. [SP=61.75 Cap=85m]
Creightons (CRL) all paper approach to buy Innovaderma rejected out of hand. Will pursue. [SP=66.64 Cap=43m]
Moonpig (MOON) the online greeting card co to float at 350p, capitalisation £1.2bn. I had no idea the market had become so big. How long will the covid boost last? [SP=NA Cap=NA]
Gfinity (GFIN) turned a profit in Q4 but "due to the project-based nature of the Company's revenue streams and some seasonality in the business in the short term it does not imply the Company will always be profitable on a monthly basis going forward." Appointed by Formula 1 Esports to deliver the Formula 1 Esports Virtual Grand Prix 2021. Formal Sale Process talks continue. [SP=5 Cap=40m]
Dev Clever (DEV) Equity Subscription Agreement with One Nine Two raising up to £10m. Initial £4m at 20p, a 1p premium. £6m is at 30p contingent on share price. Loads of warrants natch'. [SP=19 Cap=93m]
GYG (GYG) guides FY(Dec) rev €58.5m with adj EBITDA also marginally below current market expectations, and additional COVID-related exceptional costs incurred during Q4. Blames project delays into Q1. Order book up 21%. [SP=77.04 Cap=36m]
Spectra Systems (SPSY) agrees second phase of the Central Bank sensor development originally announced on 21 Oct. Worth $5.6m. "Will lead to the production of a yet unspecified number of sensors for their advanced cash processing operations." [SP=176 Cap=80m]
NetScientific (NSCI) suspended due to notification obligation pending in respect of one of its portfolio companies. NSCI is currently not in a position to issue it. What is going on? [SP=47 Cap=7m]

In line: SECN
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#383265

Postby MrContrarian » February 3rd, 2021, 7:34 am

Smallcap Sweep. 03-Feb-21


BigDish (DISH) continues to diversify from its loss-making core and is forming food technology JV with startup Amala Foods. "Amala is being established for the production and distribution of minimally processed plant-based meat products initially within Asia." Also Venture Builder to be spun out into its own listing. That was quite readable, Zak Mir must have mislaid his big book of business BS. Still a bargepole of course. [SP=1.35 Cap=5m]
Dev Clever (DEV) guides FY(Oct) accounting rev £1.2m (£480k). "Booking revenues" £2.4m. 21Q1 accounting rev broadly the same as FY20 and expects the rapid acceleration to continue. [SP=23.2 Cap=114m]
Totally (TLY) wins six-month contract extension worth c. £7.2m for urgent care. Planned Care div wins 3 year contract to provide occupational physiotherapy services to four police forces. No figure for that. [SP=32.4 Cap=59m]
STM (STM) guides FY in line with rev £24m, pretax £2m. CFO resigns, will stay for handover. She is thanked. [SP=26.56 Cap=16m]
Open Orphan (ORPH) opens quarantine clinic with up to 19 quarantine rooms. [SP=24.95 Cap=167m]
Time Out (TMO) mgmt contract for new Time Out Market in Abu Dhabi, opens 2023. Planned sites are now Planned - Dubai (2021), London (2022), Porto (2022), Abu Dhabi (2023), Prague (2025). [SP=35.1 Cap=99m]
OTAQ (OTAQ) five-year £2m Coronavirus Business Interruption Loan. "Board continues to monitor and explore its financing requirements, particularly to fund further acquisitions." [SP=28.5 Cap=9m]
Marechale Capital (MAC) not aware of any specific reason for SP rise. [SP=5.08 Cap=3m]

In line: MJH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#383525

Postby MrContrarian » February 4th, 2021, 7:33 am

Smallcap Sweep. 04-Feb-21
Roc solid, Vertu motors

Water Intelligence (WATR) increases credit facility by $3.2m in order to further accelerate growth for 2021. [SP=510 Cap=79m]
Argo Blockchain (ARB) buys 25% of Pluto Digital Assets for £1m. "Pluto invests in, incubates and advises digital asset projects based on decentralised technologies (DeTech), decentralised finance (DeFi) and networks such as Ethereum and Polkadot." "Pluto shares the same ethos as Argo." What? Making money? [SP=94.12 Cap=338m]
Vertu Motors (VTU) guides FY(Feb) adj pretax above mkt forecasts of around £18m. [SP=33.2 Cap=123m]
SigmaRoc (SRC) guides FY(Dec) rev c. £124m up 77% and EBITDA c. £23.8 up 64%, ahead of market expectations. Cites particularly strong demand for RMI and infrastructure products. [SP=64.2 Cap=179m]
EPE Special Opportunities (ESO) Jan NAV/sh 437.63p up 38%. NAV end Aug was 345.7p. [SP=263 Cap=87m]
Christie (CTG) stronger trading leads to an op profit in H2(Dec). Agency & Advisory practice seeing increased demand insolvency practitioners whilst business buyer demand remains very strong. Expects FY21 to be H2 weighted. [SP=87.63 Cap=23m]
Panoply (TPX) wins contracts in partnership with Mastek worth over £7m over 2 years. [SP=161.75 Cap=112m]
Duke Royalty (DUKE) Q3 cash rev £2.5m plus cash gain from Wellyel equity sale £1.7m. Guides Q4 cash rev £2.5m . [SP=26.6 Cap=69m]

In line: EAAS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#383797

Postby MrContrarian » February 5th, 2021, 7:28 am

Smallcap Sweep. 05-Feb-21


Distribution Finance Capital (DFCH) £40m placing at 55p, a 23% discount. Used to accelerate business plan and loan book growth [SP=70 Cap=78m]
French Connection (FCCN) re SP rise: bid approaches. Will Stephen Marks let go this time? [SP=16.5 Cap=16m]
Hargreaves Services (HSP) sells more land at Blindwells fro £9.3m min. [SP=280 Cap=90m]
Myanmar Investments (MIL) unsuspended. Was suspended after the coup. "The Company's two investments in the microfinance sector and mobile phone communication towers have so far not been directly affected by the recent events however it is too early to forecast the future impact on these investments." [SP=0.7 Cap=27m]
Falanx (FLX) £700k contract wins, £400k before Dec. Seeking CBIL loan for acquisitions and growth. [SP=1.21 Cap=6m]
Sportech (SPO) guides FY(Dec) adj EBITDA in line and cash at hand cash (excluding customer balances) ahead of expectations at c.£10.2m. Expects to raise £36.1m aggregate net cash from business sales and acquisitions. [SP=29 Cap=55m]
On the Beach (OTB) cash at hand end Jan £39m. Guidance still suspended [SP=355 Cap=559m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#384603

Postby MrContrarian » February 8th, 2021, 8:05 am

Smallcap Sweep. 08-Feb-21


1Spatial (SPA) wins £1m multi-year contract with Northern Gas Networks. Over £0.2m is recurring. [SP=27.53 Cap=31m]
UP Global Sourcing (UPGS) guides H1(Jan) rev up 11%. Expects FY rev up over 17%, ahead of (mkt?) expectations. Guides U/L pretax £10.3m (£8.2m) despite increased shipping rates. [SP=135 Cap=111m]
Yourgene Health (YGEN) guides FY(Mar) rev £18-20m, under mkt exp. Blames covid. "A number of positive developments in H2 are not only expected to contribute further to overall double-digit growth for the current year but will also provide momentum into the next FY." [SP=13.1 Cap=94m]
Gabelli Value Plus+ Trust (GVP) to hold winding-up vote. [SP=145.8 Cap=143m]
Bigblu Broadband (BBB) partnership with 'leading next-generation Asia Pacific broadband satellite operator' Kacific Broadband to provide a high-speed broadband, initially across New Zealand. Co to invest up to £1m in year 1. Expects breakeven within c.20 months of launch. [SP=105.35 Cap=62m]
Abingdon Health (ABDX) re Daily Mail article on Sat: see De, Jan RNSs "which accurately reflect the Company's position and current performance". Does not explicitly refute it then! Co doesn't quote the article and no wonder: "Ministers ignored legal advice to give failing company a huge Covid test contract leaving taxpayers with £87m bill when tests didn't work." https://www.dailymail.co.uk/news/articl ... el-it.html [SP=105 Cap=100m]
Verici Dx (VRCI) after a review initiated after the IPO in Nov, it's "accelerating its CLIA laboratory opening and approvals strategy for its two lead products, Clarava and Tuteva." [SP=92.5 Cap=131m]
Avacta (AVCT) partnership with Mologic to accelerate to market it's rapid covid test. It "will provide a faster route to market for Avacta's rapid antigen test by CE marking it for professional use under Mologic's existing ISO13485 quality system. The CE mark will then be transferred to Avacta when it receives ISO13485 accreditation, which is expected by the end of March 2021." Partnership "also provides a framework agreement for the future development of a pipeline of tests in a range of disease areas." [SP=127.5 Cap=322m]
AssetCo (ASTO) strategy change to "the development of an asset and wealth management business." Means AIM re-admission, with comletion target of 3 months. [SP=855 Cap=105m]
Omega Diagnostics (ODX) re article in FT: co is "continuing to modify its Alva-based facility to upscale significantly its lateral flow test production capacity." Will RNSs orders as received. Article says Gov't "has chosen Omega Diagnostics, SureScreen and Global Access Diagnostics to produce up to 2m lateral flow devices per day for the UK, according to two people briefed on the decision." https://www.ft.com/content/37011547-c7b ... 3e554fb4b2 [SP=69.5 Cap=125m]
Fulham Shore (FUL) rev 46% of normal through delivery and take out services, which is impressive. [SP=10.25 Cap=62m]
4d Pharma (DDDD) clinical trial collaboration and supply agreement with Merck and and Pfizer to evaluate MRx0518 in combination with BAVENCIO for the treatment of locally advanced or metastatic urothelial carcinoma. No £££. [SP=132 Cap=174m]
Lok'nStore (LOK) guides H1(Jan) rev up 11% and unit occupancy up 25%, an indicator of accelerating revenue growth. In line? [SP=671.4 Cap=198m]
Velocys (VLS) collaboration with Toyo Engineering to start the development of their commercial projects to produce Sustainable Aviation Fuel and other renewable fuels in Japan. Follows successful work already conducted with Toyo. [SP=7.58 Cap=81m]
RBG Holdings (RBGP) Convex Capital has concluded another two deals. Total fee income to date £1.1m. [SP=80.3 Cap=69m]
Seeing Machines (SEE) Driver Monitoring System now available in the Cadillac Escalade, having been integrated into the Joyson supplied Driver Attention System. [SP=11.37 Cap=425m]

In line: TRX, LOOP
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#384948

Postby MrContrarian » February 9th, 2021, 7:46 am

Smallcap Sweep. 09-Feb-21


Nucleus Financial (NUC) rec offer 188p, a 12% premium but 42% up on pre offer talks RNS. [SP=166.33 Cap=127m]
D4t4 Solutions (D4T4) CFO to leave in 3 months 'to pursue another opportunity'. He is thanked. [SP=320 Cap=129m]
CAP-XX (CPX) guides FY(Dec) rev up 10%. EBITDA loss (ex share options amortisation) c. A$1m. Order book doubled. Also co now an approved supplier to a global smart phone mfr and separately has commenced the formal process to become an accredited supplier to a global Automotive Tier 1 Component Supplier. [SP=12.5 Cap=57m]
Abingdon Health (ABDX) collaboration and co-marketing agreement with Abcam, a global leader in the supply of life science research tools and reagents. [SP=90.56 Cap=87m]
Water Intelligence (WATR) guides FY(Dec) pretax up 78%, above mkt exp. "Our results are ahead of market expectations, despite Covid." Didn't the analysts know about covid? [SP=482 Cap=74m]
Symphony Environmental Technologies (SYM) guides FY(Dec) rev up 19%, Shipping delay meant it missed a 30% rise. Op cashflow -£1.4m. No in line stmt. [SP=18.01 Cap=32m]
Numis (NUM) first 4 months of FY21 rev up 50%. "The deal pipeline for the remaining two months of the first half is encouraging." [SP=332 Cap=358m]
Northbridge Industrial Services (NBI) guides FY(Dec) adj pretax modestly ahead of management's expectation, and slightly ahead of 2019. Rev broadly flat. Sales mix reduced gross margin. Demand is expected to strengthen in Q2, across all geographies, and grow again in H2. [SP=99.65 Cap=28m]
Tavistock (TAVI) guides YTD(Jan) gross rev broadly flat due to fall in new Advisory business - lockdowns. Guides FY(Mar) EBITDA significantly up. In line? [SP=1.94 Cap=12m]
Brickability (BRCK) recent lockdowns had little material effect on trading. Guides FY(Mar) adj EBITA at least £16m. In line? [SP=66.5 Cap=153m]
Tandem (TND) guides FY(Dec) rev c. £37.1m up 75% and pretax materially up. "Stock availability, although slower than we would have hoped for, improved towards the end of the year to enable a strong finish to 2020 for the cycling businesses." Pension deficit: contribs to rise 5%. Trustees must have had their tummies tickled given the huge trading improvement. [SP=522 Cap=26m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#385304

Postby MrContrarian » February 10th, 2021, 7:49 am

Smallcap Sweep. 10-Feb-21
TOOP RNS has more paddng than my sofa

600 Group (SIXH) CFO leaves immediate effect. He is not thanked. [SP=8.9 Cap=10m]
Immotion (IMMO) wins 1 year contract to provide a new Undersea Explorer VR Theatre in the US. 50:50 revenue share and a monthly fee to defray installation costs. [SP=5.21 Cap=21m]
Toople (TOOP) wins 5 year supply contract for "a unified telecoms solution to a specialist engineering firm that designs and manufactures mercury and LED UV curing systems for the printing, coating and converting industries." Who cares what the customer does? Oh, more padding: "The firm has modern office locations, customers around the world...all of whom will benefit from enhanced technology delivered by Toople...the firm also provides customer service and support, which will also be facilitated by Toople's infrastructure." Well, you don't say. [SP=0.08 Cap=3m]
AdEPT Technology (ADT) Q3 in line. Reinstates guidance but does not say what it is. Broker note out on Research Tree. [SP=259.9 Cap=65m]
Ingenta (ING) guides FY(Dec) rev c. £10.1m, adj EBITDA c. £1.2m.Div at least 1.5p. No comparatives. [SP=82.93 Cap=14m]
Argo Blockchain (ARB) Letter of Intent to buy 320 acres of land in Texas for $17.5m in shares "with access of up to 800-megawatts of electrical power where Argo intends to build a new 200mw mining facility in the next 12 months." Will have some of the cheapest electricity in the world with the majority from renewable sources. [SP=129.5 Cap=465m]
Empiric Student Property (ESP) lockdown cuts 'revenue occupancy' to 65%, from 70% expected. Physocal occupancy 50%. No guidance. [SP=73.3 Cap=442m]
SDI (SDI) follow-on order for Atik cameras. Guides FY(Apr) rev £34m and adj pretax £6.7m, above mkt expectations. Guides FY22 rev £42m and adj pretax £8.7m, substantially above exp. [SP=122 Cap=120m]
Pittards (PTD) guides FY(Dec) rev £15.2m with H2 30% above H1. EBITDA positive in H2. Inventory levels lowest level for six years. Outlook: "Customer orders began to rise towards the end of the year, and we started 2021 with an order book stronger than the beginning of the previous 2 years." [SP=47.8 Cap=6m]
Safestyle (SFE) guides FY(Dec) rev over £113m and U/L pretax £4.7m. H2 profit in line with expectations. Outlook "strong order book and installation pipeline, the Board expects to make good progress in 2021." [SP=42.27 Cap=58m]
Starcom (STAR) guides FY(Dec) rev c. $5m ($6.8m) and adj EBITDA -£350k (+£300k). Results will have provisions for payment delays. In line? [SP=0.87 Cap=3m]
Crossword Cybersec (CSS) £1.6m placing at 260p, a 7% discount, "to drive growth in Rizikon Pro platform [SP=NA Cap=NA]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#385558

Postby MrContrarian » February 11th, 2021, 7:54 am

Smallcap Sweep. 11-Feb-21
RNSs provoke bile attack

Omega Diagnostics (ODX) Gov't contact to provide manufacturing capacity for COVID-19 lateral flow antigen tests. "The intention is that as soon as the DHSC has access to a test that has successfully passed a performance evaluation, the test will be licensed for Omega to manufacture." Expects significant volumes of tests but not in this FY. Guides FY)Mar) rev down 19%. [SP=93 Cap=167m]
One Heritage (OHG) £550k placing at 30p, a 36% discount. That's a disgrace for a 6% dilution. Don't directors realise this is a real cost to shareholders? Buys property for £725k. Related party shareholder loan facility bumped to £7.5m (£5m) as contingency for construction finance loan. [SP=47.97 Cap=NA]
BrandShield Systems (BRSD) guides FY(Dec) rev up 37% and ARR up 71%, based on a consolidation with its Dec RTO of Two Shields. Lots of excitable prose. [SP=23.75 Cap=27m]
Location Sciences (LSAI) guides FY(Dec) rev down 12%, EBITDA -£0.77m (-£1.7m). Blames covid effect of location-based advertising industry. Admin costs but 41%. "The outlook for location-based advertising is poor due to the overall impact of the pandemic on the location-based advertising industry, with mainstream media agencies now focused on media delivery rather than adopting new technologies, especially those which risk limiting delivery scale such as Verify." Co will options. Enough cash to 2022. Two dies leaving to cut cost. [SP=0.66 Cap=4m]
Petards (PEG) guides FY(Dec) rev c.£13m down 17% and adj EBITDA loss slightly better. Order book over £12m. [SP=13.1 Cap=8m]
Checkit (CKT) guides FY(Jan) rev up 6%. Expects 'operating result' (?) 15% above mkt exp (prior to any adjustment related to prior year re-statement). Outlook - accelerating its growth plans in both Europe and in the US. Will restate FY20 to reduce impairments. Makes a change from companies restating due to shenanigans. [SP=50.4 Cap=31m]
HeiQ (HEIQ) wins 4 year contract for Viroblock NPJ03 worth $1.5m min in laundry sector. Client trills that it's "an important milestone in our journey to create textile treatment solutions". Oh please. [SP=176.5 Cap=222m]
Eden Research (EDEN) time yet again for EDEN to fess up its march to the future following a another year of hype: Rev £1.6m (£2.0m) and pretax -£2.6m (-£1.4m). Blames covid and delays to product approvals. "We are proud of the resilience we have demonstrated." I've seen resilience in a chocolate fireguard. [SP=14.9 Cap=57m]
Gaming Realms (GMR) guides FY(Dec) rev c.£11.2m and adj EBITDA c.£3.1m. Where are the comparatives? Positive momentum continues into FY21. [SP=34 Cap=98m]
S & U (SUS) FY(Jan): trading robust and profitable, despite the 'induced coma' of the economy. In last 2 moths wew deal transactions have reached nearly 80% of prior. 2nd interim div of 25p (36p). [SP=2200 Cap=267m]
Clear Leisure (CLP) £680k placing at 0.6p, a 12% discount, to keep the lights on and selective further investments. [SP=0.66 Cap=4m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#385887

Postby MrContrarian » February 12th, 2021, 7:28 am

Smallcap Sweep. 12-Feb-21
MODE à la mode with Bitcoin

Northamber (NAR) H1 rev up 13%, pretax £230k (£9.8m or -£400k before property sale) . Div 0.3p unchanged. Gross margin up from 8.8% to 12.8%. [SP=60.5 Cap=16m]
Mode Global (MODE) launches Android version of its iOS app. It allows "free and instant GBP bank transfers and Open Banking top ups in British pounds, and start buying Bitcoin in just minutes." iOS app is ranked (?) no 2 in the UK finance category. [SP=NA Cap=NA]
FRP Advisory (FRP) Q1-3(Jan) strong. Will exceed market expectations (for Q1-3?), with rev >=£75m and adj EBITDA >= £21m. [SP=100.05 Cap=240m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#386791

Postby MrContrarian » February 15th, 2021, 7:44 am

Smallcap Sweep. 15-Feb-21
Mountfield cauterises bad news with 74% haircut

Mode Global (MODE) confirms Open Banking powered payments solution will launch in Q2 2021. It thinks Mastercard's hiking fees creates an opportunity. Can buy Bitcoin as well. [SP=59 Cap=48m]
Zoetic (ZOE) UK FSA Novel Foods dossier submitted, EU compliance work underway and other updates. "After consultation with its leading distribution partners, the Group has committed to ramping-up its market entrance through a calibrated and phased entry [=slow?] into stores. This careful approach has been engineered to maximise sell-through rates and revenues with demographically targeted products...anticipate this ramp-up cycle to be completed over the course of 12 to 15 months, and the information gathered during this phase will allow Zoetic to guide its strategy as the Group accelerates towards total network penetration...Initial product shipments [to US AATAC's stores] are anticipated in the coming weeks, with the programme's early requirements set to be satisfied with existing inventory and available funds. [SP=74 Cap=145m]
ValiRx (VAL) revises agreement with Physiomics. "ValiRx will benefit from Physiomics' experience in modelling the effects of prostate cancer treatment, as well the use of the latest version of its Virtual Tumour™ technology...Physiomics will receive a fee (capped at £6m) of 6% of any future net revenues." [SP=23.67 Cap=15m]
Surgical Innovations (SUN) 5 year USA distribution agreement with Microline Surgical for YelloPort+Plus and YelloPort Elite Access Devices. It's "a significant opportunity to SI for growth in the US Trocar market." [SP=2.08 Cap=19m]
Deepverge (DVRG) non-binding Heads of Terms with Microsaic Systems for a multi-year Framework. DeepVerge will be appointed as non-exclusive agent to promote Microsaic's technologies. An initial order for two units, (£50k each) plus up to £150k commitment by DeepVerge to install pilot facilities. [SP=29.9 Cap=51m]
CIP Merchant Capital (CIP) rejects 50p offer as opportunistic and a '***ing liberty. [SP=58.7 Cap=31m]
Mountfield (MOGP) troubled contruction group announces fundamental change of business and suspension. Conditionally agreed to sell Mountfield Building Group and Connaught Access Flooring - no price given! Also £3.1m placing at 0.1975p, a74% discount..` [SP=0.6 Cap=1m]
Microsaic Systems (MSYS) framework agreement - see DeepVerge RNS. [SP=0.27 Cap=16m]
Toople (TOOP) five new contract wins with leading UK businesses. [SP=0.09 Cap=4m]
St Peter Port Capital (SPPC) will auction all assets and return cash and liquidate. It's a variation of the previous proposal. [SP=3.86 Cap=2m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#387136

Postby MrContrarian » February 16th, 2021, 7:47 am

Smallcap Sweep. 16-Feb-21


Town Centre Securities (TOWN) FD leaves end Feb and begins 'garden leave'. New FD needed to increase the focus on reducing costs. He is thanked. What happened there? [SP=117.16 Cap=62m]
Gama Aviation (GMAA) FY(Dec) trading: U/L performance, excluding share of losses from its associate China Aircraft Services remained stable in H2. Operational performance partially recovered in H2. [SP=38 Cap=24m]
Supply @ME Capital (SYME) update on unsuspension: talking to FCA, aware that process has taken longer than expected. Er, that's it. [SP=0.51 Cap=167m]
Fusion Antibodies (FAB) CEO scarpers to pursue other opportunities but will become a consultant to the Company. He is thanked. [SP=135 Cap=34m]
Avacta (AVCT) first data for its rapid covid test "show excellent performance of the test in identifying patients with an infectious viral load and no false positive results". Sample size only 76 though. Proceeds to full clinical validation. [SP=154.5 Cap=391m]
Fox Marble (FOX) FY(Dec) rev down 50% of €0.7m as block marble sales fell to €0.1m (€1.2m) due to global travel restrictions impeding international trade in blocks and fall in China demand. "Confident that 2021 will see a gradual return to normal sales volumes." [SP=2.3 Cap=9m]
Mercantile Ports & Logistics (MPL) wins 5 year contract for bulk cargo, expects 2-3MT over next 3 years. Commences March with significant ramp up in Sep. Also cement contract. "I look forward to updating the market as we close further contracts with pipeline customers throughout the course of the year". [SP=0.39 Cap=7m]
Ocean Outdoor (OOUT) guides FY(Dec) rev down 38% and adj EBITDA -£0.4m (+£33m). "The reintroduction of lockdown measures across all territories in Q4 led to brands pulling back on advertising spend and deferring campaigns." Guidance still withdrawn. [SP=7.1 Cap=390m]
Nexus Infrastructure (NEXS) AGM stmt: trading conditions in TriConnex and eSmart "continue to be positive with both businesses carrying significant momentum" but Tamdown more in-line with the downside scenario. "With a strong balance sheet and order book of £279m, Nexus remains on-track to implement its recovery and growth strategy." [SP=164.95 Cap=75m]
Calnex Solutions (CLX) guides FY(Mar) rev and profit ahead of market expectations with higher margins. No £££. "While we have now started to see some signs that this early pull through of orders is reverting to more normal levels, we anticipate entering FY22 with a healthy order book." [SP=116.24 Cap=102m]
Arden Partners (ARDN) FY(OcT rev down 11%, EPS -5p (-8.9p). "Whilst the macro outlook remains uncertain, our second half performance and more recent trading, together with less volatile equity markets and a good M&A pipeline, gives us confidence of a return to profitability in the current financial year." [SP=11.9 Cap=3m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#387345

Postby MrContrarian » February 17th, 2021, 7:31 am

Smallcap Sweep. 17-Feb-21
Costain finds A465 exit at last

Gattaca (GATC) guides H1(Jan) Net Fee Income down 34%. "NFI recovery for FY21 is likely to be at a slower rate than previously forecast. However, as a result of appropriate management of the cost base and the underlying improvements in the business we are seeing through the acceleration of our Group-wide Improvement Plan, we currently expect full year underlying PBT to be in line with market expectations." [SP=98 Cap=32m]
Pebble Beach System (PEB) guides FY(Dec) rev down 25% and adj EBITDA c. £2.6m (£3.8m). "Going into 2021 there continues to be understandable delays in the investment decisions of our customers given COVID-19. However, the Group's pipeline remains very strong." [SP=10.01 Cap=12m]
Pressure Technologies (PRES) £3.1m promissory note from sale of disposal of PT Biogas was repaid early [SP=105.08 Cap=33m]
Deepverge (DVRG) wins £3.6m order for Modern Water (its recent acquisition) equipment for delivery this FY. [SP=29.9 Cap=51m]
ECSC (ECSC) £550k contract wins in its Managed Detection and Response (MDR) division. [SP=65.1 Cap=7m]
Costain (COST) finally settles compensation on its disastrous A465 contract, in line with its provision. [SP=59 Cap=162m]
Creo Medical (CREO) guides FY(Dec) rev £9m (£0.01m), marginally ahead of management expectations. "With the roll out of COVID-19 vaccines underway, we look forward to realising our goals this year and beyond." [SP=216 Cap=341m]
Chrysalis Investments (CHRY) vote on placing up to 600m shares. "The Company's Investment Adviser has a strong pipeline of investment opportunities totaling ca.£1 billion and has identified potential follow-on opportunities of up to ca. £250m that may be available over the coming months." [SP=225 Cap=902m]
Marlowe (MRL) expects FY(Mar) at the top end of market expectations. Sets 3 year tgt of c.£500m rev and adjusted EBITDA of c.£100m. Adj divisional EBITDA margin target of 20% (was 15%). [SP=636 Cap=397m]
SimplyBiz (SBIZ) CFO leaves end March. He is thanked. [SP=188 Cap=182m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#387621

Postby MrContrarian » February 18th, 2021, 7:33 am

Smallcap Sweep. 18-Feb-21


KKV Secured Loan Fund (KKVL) Buy-back of investment boost NAV by 4.91p, based off the last published NAV of 36.19p. [SP=15.21 Cap=103m]
MYCELX (MYX) sells US office for $2.78 net of debt, a $2.53m book gain. [SP=27.03 Cap=5m]
Trifast (TRI) guides FY rev slightly ahead of market expectations of c.£172m. Rev up 5% in recent 4 months. "Pre-Brexit stock piling, in our other distributor business, led to a strong December in the UK region. However, border issues have created logistical challenges since 1 January on the EU distributor side (c.5% of Group revenues)...The current container freight issues are increasing transport costs around the world. Furthermore, a global shortage of steel as manufacturing volumes recover, is causing raw material pricing and lead time pressures for both our internal and third party manufacturers. This is creating additional margin pressure which we are working hard to mitigate." [SP=135 Cap=184m]
Arbuthnot Banking (ARBB) guides FY(Dec) pre-tax loss better than market expectations. Q4 loan enquiries improved. "The return to pre-pandemic credit appetites enabled the business to develop new lending pipelines that we expect to draw in 2021." [SP=909.75 Cap=137m]
OptiBiotix Health (OPTI) guides FY(Dec) rev £1.5m up 103% and admin costs £1.6m down 28%. £7m gain on holding in SkinBioTherapeutics. Holding reduced to <25% and will now be treated as an investment. "Investor and consumer interest in health and wellbeing and the microbiome is a growing trend and, as a result, the Company's market opportunity is large and expanding." [SP=61 Cap=54m]
ADVFN (AFN) H1(Dec) rev up 28%, pretax £264k (-£402k). "While we expect growth at a similar pace in the coming half, our strategy is to be very conservative and we will expend our energies growing our platform's capacity rather than looking to broaden our audience." [SP=38 Cap=10m]

In line: ESYS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#387879

Postby MrContrarian » February 19th, 2021, 7:31 am

Smallcap Sweep. 19-Feb-21
Path placing pathetic

Provexis (PXS) £50k (really?) placing at 0.75p, a 7.4% discount. for 'additional working capital'. There was a £1m placing in Dec! [SP=0.85 Cap=19m]
SourceBio (SBI) wins contract to manage the delivery of community based COVID-19 testing services through mobile testing units. Co will manage the 4 units on behalf of Mitie for the remainder of the pilot and is working towards continued involvement in a potential UK-wide programme. No £££. [SP=193.44 Cap=143m]
Path Investments (PATH) £3.5m placing at 0.25p, an absurd 70% discount, to support this sub-scale tinpot's 'continuing investment strategy'. Also warrants at 0.5p as if the deal wasn't sweet enough. ""We are delighted with the support we have received for the Fundraise." What? You've benn totally stiffed. [SP=0.85 Cap=2m]
IDOX (IDOX) approach at 75p, a 22% premium. Co rebuffed two very recent previous indicative offers from offeror at 67p and 70p. 39% premium to first approach on Feb 9. [SP=61 Cap=271m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#388598

Postby MrContrarian » February 22nd, 2021, 7:47 am

Smallcap Sweep. 22-Feb-21
SHOE FD gets the boot

Avacta (AVCT) re press report:"The press report this weekend incorrectly stated that a saliva-based rapid antigen test from Avacta had been evaluated at Porton Down. In fact, the evaluated test was the anterior nasal swab test that has subsequently generated the excellent initial clinical performance data outlined above. However, in its evaluation Porton Down used artificial samples and did not use clinical samples." [SP=183 Cap=463m]
Fonix Mobile (FNX) CFO resigns, leaves end Mar. "Mr Horner was appointed to the Board to assist with the Company's admission to AIM in October 2020. Whilst Mr Horner steps down from the Board, he remains a very supportive shareholder in the Company." He is thanked. It would be an outrage if he had a 1 year or longer contract then and got a big payoff. [SP=157.5 Cap=157m]
Shoe Zone (SHOE) FC scarpers. He is not thanked. [SP=71 Cap=35m]
OnTheMarket (OTMP) guides FY (Jan) rev c. £23m and adj op profit c. £2.3m, cf prev guidance of >=£22.5m and £1.5m. Expects marketing expenditure to return to more usual pre-COVID levels and plans to increase investment in new products and services and to invest further in internal website development resources. [SP=108 Cap=78m]
Directa Plus (DCTA) following a trial, wins 3 year supply agreement and a Strategic R&D Agreement with Lithium Sulphur battery co NexTech Batteries. No $$$. [SP=130 Cap=80m]
CentralNic (CNIC) buys Wando Internet Solutions for €5.4m plus €5.4m earn out. Wando's FY20 rev €4.9m and EBITDA €1.2m. [SP=95.43 Cap=221m]
Litigation Capital Managemen9 (LIT) additional $50m credit facility at 8% over LIBOR plus profit share. Total 13% max. For a secured loan! [SP=68 Cap=79m]
Ridgecrest (RDGC) cash sell unsuspended since "the settlement situation has now improved". What's that about? [SP=2.1 Cap=10m]
Tirupati Graphite (TGR) success in trials for the manufacture of battery grade spherical graphite (SPG) for Li-On cells. "Commissioned development and optimisation for the first in a series of commercial scale 3,000tpa SPG manufacturing plants with German specialist and initiated discussions with prospective buyers of SPG including automobile majors, battery and anode manufacturers." [SP=77 Cap=58m]
Air Partner (AIR) reiterates FY(Jan) guidance. Final div 1.6p. Post-pandemic div cover target 3-3.5x. [SP=70.83 Cap=45m]
Image Scan (IGE) AGM stmt: "The order pipeline in both security and industrial markets is showing some signs of recovery and the performance in the second half will be dependent on timely receipt of those orders." [SP=2.77 Cap=4m]
Solid State (SOLI) guides FU [SP=770 Cap=66m]
Solid State (SOLI) guides FY(Mar) rev broadly in line and profits ahead of consensus forecasts. "The strengthening pound has resulted in currency headwinds at a revenue level, albeit the Group's natural hedge mitigates the impact on profits." May bbe programme delay in FY22 but expects trading activity flat. [SP=770 Cap=66m]
Clear Leisure (CLP) £1m placing at 1p, a 20% discount (not mentioned) to investor John Story. Takes him to 11.14% 2p warrants too. [SP=1.3 Cap=10m]

In line: ORCH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#389010

Postby MrContrarian » February 23rd, 2021, 7:33 am

Smallcap Sweep. 23-Feb-21


Kanabo (KNB) has signed its first UK medicinal cannabis distribution framework agreement. "The project aims to create the UK's largest body of evidence for the effectiveness and tolerability of medical cannabis." No £££. [SP=25.4 Cap=91m]
Vela Technologies (VELA) tinpot investing vehicle makes £1.5m placing at 0.09p, a 3% premium. to take advantage of investment opportunities and for working capital. With warrants at 0.125p, only 38% above placing price. [SP=0.09 Cap=11m]
Diurnal (DNL) Chronocort distribution and marketing agreement with Consilient Health for the Nordics, ahead of anticipated European recommendation for approval. Extends relationship with Consilient Health. [SP=62 Cap=86m]
Non-Standard Finance (NSF) FY(Dec) trading: net loan book down 27% after "a solid trading performance" in H2.. Branch-based lending weak in Nov & Dec. Targets substantial equity raise in Q2 to fix material uncertainties regarding going concern. [SP=3.51 Cap=11m]
Zotefoams (ZTF) new Polish factory starts production. [SP=430 Cap=209m]
"Begbies Traynor (BEG) guides FY(Apr) at least in line with pretax expectations of £10.2m-£10.7m. Well positioned to deliver the anticipated material growth in earnings in FY22.
[SP=102.5 Cap=131m]"

In line: TRCS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#389402

Postby MrContrarian » February 24th, 2021, 7:35 am

Smallcap Sweep. 24-Feb-21


Novacyt (NCYT) R&D update including trial of covid lab test using saliva at AstraZeneca: 54000 tests averaged sensitivity of ≥95% and 100% specificity. [SP=684 Cap=560m]
Celtic (CCP) team manager resigns. He is thanked. Sports pages have more excitable reports. [SP=102.5 Cap=97m]
Avacta (AVCT) starts full clinical validation for CE MArk of rapid covid test - potential commercial launch for professional use end 2020Q1. Progess in both divs "has already enabled us to deliver major value inflection points during the first weeks of 2021." Pass the MBA sick bag. [SP=178 Cap=451m]
Best of the Best (BOTB) ends offer talks. Recent 20% fall must be a coincidence. Trading in-line. [SP=2450 Cap=230m]
Angling Direct (ANG) FY(Jan) in line with rev up 27%, pre IFRS-16 EBITDA at least £3.8m but no FY22 guidance. [SP=78.08 Cap=60m]
LSL Property Services (LSL) continued to deliver strong financial performance in first 7 weeks. [SP=241 Cap=253m]
Zoetic (ZOE) CBD products "now set to be stocked by one of the largest tobacco-focused retail chains in the US...a pivotal moment in the progress of our US rollout." [SP=75 Cap=147m]
Electra Private Equity (ELTA) all portfolio companies is trading in line. [SP=319 Cap=122m]

In line: PHD
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#389829

Postby MrContrarian » February 25th, 2021, 7:39 am

Smallcap Sweep. 25-Feb-21


7digital (7DIG) wins 2 year contract from FORME Life to cache or stream music content that can then be synchronised with a training video. The FORME Life hardware and programming launches in Spring 2021 in the US. No $$$. [SP=1.44 Cap=39m]
Dev Clever (DEV) Novation of subscription agreement from One Nine Two Pte Ltd to Sitius, an investment vehicle wholly owned by Dr David vonRosen. Sitius has conditionally agreed to acquire a material interest in the Company by way of entering into a series of transactions. Also Grant of Call Option agreement by CEO to Sitius. [SP=26.8 Cap=137m]
Asimilar (ASLR) subsidiary has assigned its right to subscribe for up to 30m shares in Dev Clever to Sitius. See DEV RNS. [SP=32.22 Cap=35m]
Gear4music (G4M) FY(Mar) EBITDA guidance hiked to at least £18.2m (prev £16.5m). [SP=713.51 Cap=149m]
Trakm8 (TRAK) wins long term contract for over 1,000 RH600 integrated telematics and cameras systems. No £££. Guides H2 rev up 15% on H1, FY 20% down. [SP=14.75 Cap=7m]
Digitalbox (DBOX) guides FY(Dec) rev flat at c.£2.2m and adj EBITDA c. £0.3m (£0.5m). Q1 trading ahead of initial expectations. "Digitalbox made significant and exciting progress through these challenging times." Well the numbers don't say that. [SP=6.13 Cap=7m]
Ilika (IKA) Stereax new factory update. Doesn't think construction material shortages will have a fundamental effect on expected timings. So nothing new really but IKA uses RNSs like an airbed pump for its shares. [SP=215 Cap=299m]
Macfarlane (MACF) FY(Dec) ahead of mgmt's previous expectations. Rev up 2%, EPS up 6%, FY div 2.55p (0.69p). [SP=85 Cap=134m]

In line: CPX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1071
Joined: November 4th, 2016, 2:45 pm
Has thanked: 36 times
Been thanked: 1035 times

Re: MrC's Smallcap Sweeps for Feb 2021

#390137

Postby MrContrarian » February 26th, 2021, 7:33 am

Smallcap Sweep. 26-Feb-21
Ashes and hashes

Argo Blockchain (ARB) another 15MW of electricity turned to ashes and hashes as 4500 new mining machines start. [SP=265.54 Cap=956m]
Motif Bio (MTFB) completes sale of Motif Inc's operations. Remains suspended pending RTO. [SP=0.5 Cap=3m]
Aquis Exchange (AQX) gudes FY(Dec) rev at least £11m, marginally ahead of market expectations and a pretax profit, ahead of market expectations. [SP=535 Cap=145m]
K3 Business Technology (KBT) sells managed services unit, Starcom Technologies for £14.7m. £10m book gain. [SP=129.25 Cap=56m]
Alpha Real Trust (ARTL) NAV at end Dec 209.3p/sh (Sept 211.1p). [SP=157 Cap=95m]
Escape Hunt (ESC) has now exchanged contracts to acquire its French master franchise partner. Guides FY rev c. £2.6m (£4.9m) and adj EBITDA -2.0m (-£2.1m). "Board is confident that both consumer and corporate demand will return strongly when the restrictions currently in place are lifted." [SP=24.2 Cap=21m]
ASA International (ASAI) guides FY(Dec) operating results below mgmt expectations "with collection efficiency recovering at a slower pace than anticipated in India and, as result, higher than expected credit losses with PAR>30 in India having increased to 31.7%." [SP=182 Cap=182m]
Danakali (DNK) CEO let go to cut costs and will support an orderly transition Exec Chmn will assume role. [SP=29.6 Cap=176m]
Universe (UNG) CEO scarpers, remains for transition. He is thanked. [SP=3.01 Cap=8m]
Fuller, Smith & Turner (FSTA) FD to leave, going to Marlowe after successor found. He is thanked. [SP=902 Cap=292m]

In line: CGS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian


Return to “Share ideas”

Who is online

Users browsing this forum: No registered users and 11 guests